Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide LAR for prevention of axillary lymphoceles after breast cancer surgery
2010-018795-24Phase 2Active
- Sponsor
- Alliance pour la Recherche en Cancérologie
- Start
- Feb 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pasireotide LAR in breast cancer and lymphocele, sponsored by Alliance pour la Recherche en Cancérologie. Started Feb 2010; status: active.
02
Drugs
pasireotide LAR
03
Conditions
breast cancerlymphocele
Beyond the preview
Go deeper on 2010-018795-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018795-24.